Covered recipient · General Payments record
JOSHUA L MCDANIEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$869.95
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $762.89 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $341.65 | 21 |
| UCB, Inc. | $102.83 | 3 |
| EISAI INC. | $102.57 | 4 |
| TONIX PHARMACEUTICALS, INC. | $51.83 | 2 |
| Lundbeck LLC | $44.49 | 2 |
| PFIZER INC. | $36.91 | 2 |
| ARGENX US, INC. | $31.48 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $26.83 | 1 |
| Teva Pharmaceuticals USA, Inc. | $24.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.94 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625979 | CMS |
| ABBVIE INC. | $17.17 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625981 | CMS |
| ABBVIE INC. | $28.92 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625983 | CMS |
| ABBVIE INC. | $8.03 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625985 | CMS |
| ABBVIE INC. | $26.49 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625987 | CMS |
| ABBVIE INC. | $16.26 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625989 | CMS |
| ABBVIE INC. | $14.66 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625991 | CMS |
| ABBVIE INC. | $9.80 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625993 | CMS |
| ABBVIE INC. | $9.78 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625995 | CMS |
| ABBVIE INC. | $16.05 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625997 | CMS |
| ABBVIE INC. | $25.21 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107625999 | CMS |
| ABBVIE INC. | $13.78 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626001 | CMS |
| ABBVIE INC. | $8.74 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626003 | CMS |
| ABBVIE INC. | $23.45 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626005 | CMS |
| ABBVIE INC. | $21.37 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626007 | CMS |
| ABBVIE INC. | $12.66 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626009 | CMS |
| ABBVIE INC. | $17.46 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626011 | CMS |
| ABBVIE INC. | $7.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626013 | CMS |
| ABBVIE INC. | $8.09 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626015 | CMS |
| ABBVIE INC. | $13.04 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626017 | CMS |
| ABBVIE INC. | $20.95 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107626019 | CMS |
| ARGENX US, INC. | $31.48 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142147252 | CMS |
| Boston Scientific Corporation | $26.83 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092356051 | CMS |
| Eisai Inc. | $24.42 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110806924 | CMS |
| Eisai Inc. | $19.35 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110806922 | CMS |
| Eisai Inc. | $27.26 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110806926 | CMS |
| Eisai Inc. | $31.54 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110806928 | CMS |
| Lundbeck LLC | $19.60 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146058682 | CMS |
| Lundbeck LLC | $24.89 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146058684 | CMS |
| PFIZER INC. | $23.26 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131528704 | CMS |
| PFIZER INC. | $13.65 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131494705 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.30 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151582023 | CMS |
| Tonix Medicines, Inc. | $24.97 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142469874 | CMS |
| Tonix Medicines, Inc. | $26.86 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142469876 | CMS |
| UCB, Inc. | $32.67 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143050723 | CMS |
| UCB, Inc. | $34.74 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143050725 | CMS |
| UCB, Inc. | $35.42 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143050727 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.